Deere & Company (DE)
NYSEIndustrialsFarm & Heavy Construction MachinerySnapshot 2026-07-07
$603.46-5.00%
Close 2026-07-07 · 1-day change
Reading DE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DE free→NYSEIndustrialsFarm & Heavy Construction MachinerySnapshot 2026-07-07
Reading DE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DE free→QuarterlyIQ Insights · DE
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $603.46. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $603 DE trades at 34× p/e, in line with its 31× p/e peer median — but our blended $471 fair value sits below the price. We hold it with low confidence: our number sits well below the analyst range. Analysts target $625–$812. Note: our $471 fair value sits below the entire analyst range ($625–$812). The flat-multiple read looks rich, but earnings are inflecting up — trailing growth is accelerating and forward estimates confirm — so we've softened our read rather than brand an accelerating name expensive. Even valued only for durable growth at sustainable margins, it's worth about $648 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
$625.00 – $812.00 (median $685.00) · 5 analysts · as of 2026-07-02
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 74% over what the business is worth with no growth; closing that gap needs roughly — years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $17.45/sh owner earnings.
Roughly priced in line with peers.
Richer than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $718.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $503.51 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $419.93 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $105.09 | — | — | TTM | high |
| graham number | 12M | $200.50 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $448.12 | 19.0 | 34.60 | TTM | high |
| Peer P/FCF | 12M | $390.60 | 28.1 | 13.91 | TTM | high |
| Peer P/E | 12M | $551.57 | 31.3 | 17.65 | TTM | high |
| Peer P/S | 12M | $623.25 | 3.5 | 176.37 | TTM | high |
| PEG | 12M | $771.90 | 43.7 | 17.65 | TTM | high |
| residual income | 12M | $134.75 | — | — | TTM | high |
| Own P/E history | 12M | $437.02 | 24.8 | 17.65 | TTM | high |
| triangulated | 12M | $577.10 | 31.3 | 18.47 | Triangulated | high |
| Peer P/FCF | 3Y | $594.05 | 28.1 | 21.16 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 5Y | $785.63 | 28.1 | 27.99 | Hist. CAGR(prov.) | medium |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.